If you find yourself jolting awake in the early morning hours, it may not necessarily be due to unexplained insomnia. Instead ...

With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...

Rep. Vern Buchanan and Dr. Mark Hyman are advocating for a “Food as Medicine” movement to prevent chronic diseases and save ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

Researchers have found that engaging in moderate to vigorous physical activity during leisure time, regardless of ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.